|
|
|
DDF - Liver Programme, 22 - 25 June, ExCeL
The DDF 2015 event replaces this year's BASL Annual Meeting and will deliver a Liver Stream. This is your Annual Meeting.
>If you still need to register please click here.
>View the Liver programme highlights here.
>View the full interactive programme here.
REGISTER
BASL members will need to supply a membership ID number when registering. To acquire this, log in to your membership profile on the BASL website via 'Manage Accounts'
|
|
BASL School of Hepatology July 2015
Saturday, July 11, 2015 - Sunday, July 12, 2015
Fitzwilliam College, University of Cambridge
This event is aimed at SpRs/Doctors in Training with a NTN.
Places are on a first come first served basis.
This is a weekend residential event, which is free to BASL in training members, non members £125
This includes bed and breakfast accommodation for Friday and Saturday night and all meals during the event.
Event themes:
Cirrhosis complications, Autoimmune and biliary disease, Inherited liver disorders, NAFLD and alcoholic hepatitis, Pathology and radiology for the hepatologist.
TO BOOK
To complete the online registration form click here. The event is limited to 40 places, available to SpRs/Doctors in Training with a NTN.
If you have any queries, please contact the Secretariat on admin@basl.org.uk or +44 (0)1543 442154.
|
|
Nursing at DDF 22nd - 25th June 2015.
Please click here for a small selection of programme highlights for Nurses at the Digestive Disorders Federation Conference at ExCeL London.
|
|
Nurse Bursaries for DDF 2015
BASL will be administering bursaries to support attendance for UK nurses at DDF 2015, 22-25 June www.ddf2015.org.uk
The application form is currently being finalised. There will be further information on the BASL website shortly.
To register your interest contact Jane.Douthwaite@execbs.com
|
|
Treatment of HCV in Cirrhosis- Update from Graham Foster
I am writing to update you on the progress of accessing all oral antiviral therapy for patients with chronic hepatitis C. At present patients with decompensated cirrhosis are offered treatment with all oral agents as part of the Early Access Programme. This is delivered through 17 centres and the programme will continue for the foreseeable future. We hope to extend the offer of all oral antiviral therapy to all patients with cirrhosis in the very near future and, towards the end of the year, we hope to be able to offer these treatments to patients with less advanced fibrosis. We intend to deliver therapy to patients with cirrhosis and less advanced fibrosis through networks with patients managed and treated at their local centre.
As you know we had hoped to offer therapy to patients with cirrhosis in April but I am afraid that this deadline has now slipped due to the processes and committees such policies need to go through at NHSEand although we hope to be able to start patients on treatment in May there may be some further slippage and I think it would be prudent to advise patients that treatment is likely to commence in June. The CRG will continue to work with NHS England to ensure that these therapies are made available as quickly as possible
|
|
Nurse Clinics 2015 Seventh Annual Conference
Thursday 19 November 2015, London
Nurse Clinics 2015 will provide specialist nurses with a valuable opportunity to hear national updates and best practice for working at advanced practice, and practical guidance for setting up and running nurse led clinics and services in primary and secondary care.
For more information visit:
http://www.healthcareconferencesuk.co.uk/nurse-clinics-2015
|
|
Final recommendations on Therapy for Chronic Hepatitis C
The treatment options for patients with chronic hepatitis C are expanding rapidly. To guide clinicians and commissioners the national societies (BASL, BHIVA BIA, BSG, BVHG) representing clinicians with an interest in this area convened a meeting to provide evidence based treatment and management recommendations.
For a full report please click here
|
|
Multinational study comparing the severe form of steatohepatitis by the CLASH Study collaboration group
Please would you take part in a brief survey on a multinational study comparing the severe form of steatohepatitis that is found in patients with alcoholic hepatitis, with the mild form of steatohepatitis that is found in early asymptomatic patients. The study, entitled CLASH (Clinical, Histological and Molecular Characterization of two Subtypes of Alcoholic Steatohepatitis), incorporates a proposal to revise the nomenclature. For more information please click here.
Please follow this link:
https://www.surveymonkey.com/s/6T2F32G.
Your responses will be treated with confidentiality and reported anonymously.
|
|
UK-PBC survey - Management of Primary Biliary Cirrhosis
Primary biliary cirrhosis is an area of increasing clinical research activity and our understanding of disease mechanisms, clinical care, and new potential therapies is evolving.
Through this on-line survey we aim to:
* Establish current practice in management of PBC in the UK
* Identify knowledge amongst those involved in the care of patients with PBC regarding current research and emerging therapies.
To take part in this 5 - 10 minute survey please click https://www.surveymonkey.com/s/MGKRXL3
|
|
NICE Final Guidance on Rifaximin for preventing episodes of overt hepatic encephalopathy [ID496]
This is published on the NICE website: www.nice.org.uk/guidance/TA337.
There will also be a version of the guidance available for people using services, carers and the public called ‘Information for the public’. Additionally, the documentation used to develop the guidance such as the underpinning evidence submissions, will remain on the website.
A copy of the guidance is available for you to download from NICE Docs:
https://appraisals.nice.org.uk/request/4066
|
|
Change to BASL NF Committee
As she is about to leave her current role in Hepatology, Amanda Clements will be standing down from the BASL NF Committee with immediate affect.
She will be very much missed as she has made a huge contribution to our Association during her time as BASLNF Chair, and as part of the Nurse Committee
|
|
Your Liver Campaign: Social Media
Thank you to all involved in making this campaign the biggest of its kind, and helping us to raise awareness for the liver conditions that affect so many in the UK and worldwide.
In order to spread this campaign as far and wide as possible, it would be great if you would like to share it through your online and social media platforms. The hashtags we will be using are #yourliver #liverhealth #loveyourliver #liver.
Let’s make this the biggest campaign we possibly can! Let’s get it trending!
|
|
Help with email addresses....
Do you know of any members who are not receiving the member communications? It may be that their email address has changed and we are not aware. Please ask them to contact jane.douthwaite@execbs.com at the BASL Secretariat and we will update their record. Thank you!
|
|
|
|
|
|